cAMP and 'death signals' in a myeloid leukaemia cell: from membrane receptors to nuclear responses: a review.
Ruchaud
S
S
INSERM U-301, Centre G. Hayem, Hôpital Saint-Louis, Paris, France.
Lanotte
M
M
D000818:Animals; D017209:Apoptosis; D002467:Cell Nucleus / Q000502:physiology*; D000242:Cyclic AMP / Q000502:physiology*; D051786:Cyclic AMP Response Element Modulator; D004268:DNA-Binding Proteins / Q000378:metabolism; D006410:Hematopoiesis / Q000276:immunology / Q000502:physiology; D006801:Humans; D007378:Interleukins / Q000502:physiology; D007951:Leukemia, Myeloid / Q000276:immunology / Q000473:pathology* / Q000503:physiopathology*; D008954:Models, Biological; D011494:Protein Kinases / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000502:physiology*; D012097:Repressor Proteins / Q000378:metabolism; D015398:Signal Transduction
D004268:DNA-Binding Proteins; D007378:Interleukins; D019253:Proto-Oncogene Proteins c-bcl-2; D011956:Receptors, Cell Surface; D012097:Repressor Proteins; D051786:Cyclic AMP Response Element Modulator; D000242:Cyclic AMP; D011494:Protein Kinases